Marshall Wace North America’s Mesa Laboratories MLAB Stock Holding History

Marshall Wace North America’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.82M	Sell	6,033 -1,957	-24%	-$556K	0.01%	752
2021 Q2	$2.17M	Buy	7,990 +136	+2%	+$34.5K	0.01%	780
2021 Q1	$1.91M	Sell	7,854 -666	-8%	-$183K	0.01%	842
2020 Q4	$2.44M	Sell	8,520 -1,441	-14%	-$396K	0.01%	704
2020 Q3	$2.54M	Sell	9,961 -3,828	-28%	-$910K	0.02%	527
2020 Q2	$2.99M	Buy	13,789 +13,504	+4,738%	+$3.11M	0.02%	474
2020 Q1	$64K	Buy	+285	New	+$70.3K	﹤0.01%	1052

Other funds holding MLAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Marshall Wace North America's MLAB Position: Q3 2021 in Review

Marshall Wace North America reduced its Mesa Laboratories (MLAB) stake by 24% in Q3 2021, selling an estimated $556K and leaving 6,033 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #752.

Marshall Wace North America first reported a position in MLAB in Q1 2020 and has held it in 7 quarters since. The position peaked at $2.99M in Q2 2020. 172 funds tracked by Wall St. Rank hold MLAB as of Q3 2021.

Marshall Wace North America held 6,033 shares of Mesa Laboratories worth $1.82M as of Q3 2021.
Marshall Wace North America sold 1,957 Mesa Laboratories shares in Q3 2021, an estimated $556K.
Mesa Laboratories made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #752 holding.
Marshall Wace North America first reported a position in Mesa Laboratories in Q1 2020 and has held it in 7 quarters since.
Marshall Wace North America's Mesa Laboratories position peaked at $2.99M in Q2 2020.
172 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.